Coexistence of anti‐MDA5 and anti‐PL‐7 in a patient with dermatomyositis: A case report

Coexistence of anti‐MDA5 and anti‐PL‐7 in a patient with dermatomyositis: A case report

Abstract Coexisting anti‐MDA5 and anti‐PL‐7 antibodies are extremely rare. Anti‐MDA5 is associated with rapidly progressive interstitial lung disease (RP‐ILD), while anti‐PL‐7 is often associated with chronic or subacute ILD and better outcomes than RP‐ILD. We report a 41‐year‐old woman diagnosed wi...

Full description

Bibliographic Details
Main Authors:	Hongyan Fu, Shaofeng Sun, Hong Zhang, Shuhong Chi, Weirong Ma, Guilan Yang, Juan Chen
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Clinical Case Reports
Subjects:	anti‐MDA5 anti‐PL‐7 dermatomyositis interstitial lung disease myositis‐specific autoantibodies
Online Access:	https://doi.org/10.1002/ccr3.6840

Similar Items

The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients
by: Xixia Chen, et al.
Published: (2022-08-01)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
by: Anne-Claire Billet, et al.
Published: (2022-12-01)

Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
by: Akira Yoshida, et al.
Published: (2023-12-01)

Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report
by: Khalila Nainia, et al.
Published: (2024-05-01)

Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report
by: Semra Ayduran, et al.
Published: (2024-12-01)

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
by: B. Palterer, et al.
Published: (2017-08-01)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
by: Fang Chen, et al.
Published: (2022-05-01)

Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort
by: Sai K. Koyoda, et al.
Published: (2025-01-01)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
by: Houari Aissaoui, et al.
Published: (2021-04-01)

Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study
by: Xu X, et al.
Published: (2025-02-01)

Evaluation of the Performance of an Indirect Immunofluorescence Assay for the Detection of Anti-MDA5 Antibodies
by: Anaïs Nombel, et al.
Published: (2022-11-01)

Editorial: Anti-MDA5-Positive Dermatomyositis
by: Takahisa Gono, et al.
Published: (2022-05-01)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
by: Anca Bobirca, et al.
Published: (2022-07-01)

Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease
by: Kaikai Zhao, et al.
Published: (2025-02-01)

Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis
by: Tao Liu, et al.
Published: (2022-08-01)

Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study
by: Hongxia Xin, et al.
Published: (2025-01-01)

Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01)

Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
by: Huyan Wang, et al.
Published: (2023-07-01)

Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study
by: Qiang Ji, et al.
Published: (2023-11-01)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)

Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review
by: C.G.V. de Carvalho, et al.
Published: (2024-10-01)

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
by: Toshiya Hiramatsu, et al.
Published: (2022-01-01)

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
by: Darija Logvinova, et al.
Published: (2024-11-01)

A less common case of anti‐MDA5 and anti‐Ro52 antibody‐positive juvenile dermatomyositis complicated with macrophage activation syndrome
by: Li Zhang, et al.
Published: (2024-03-01)

Management of Myositis-Associated Interstitial Lung Disease
by: Tomoyuki Fujisawa
Published: (2021-04-01)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
by: Yuan Xue, et al.
Published: (2023-01-01)

14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report
by: Mitchell Kinkor, et al.
Published: (2024-09-01)

Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features
by: Laurence Pacot, et al.
Published: (2020-03-01)

Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
by: Yuanyuan Niu, et al.
Published: (2024-10-01)

Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering
by: Ruru Guo, et al.
Published: (2024-03-01)

Anti-synthetase syndrome with anti-PL-7 antibody positive in a child: a case report and literature review
by: Jia Liu, et al.
Published: (2025-03-01)

Successful tocilizumab treatment for rapidly progressive interstitial lung disease with anti-MDA5-positive juvenile dermatomyositis: a case report and literature review
by: Lingzhi Qiu, et al.
Published: (2024-11-01)

Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease
by: Yan Li, et al.
Published: (2023-06-01)

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
by: Man Luo, et al.
Published: (2022-05-01)

Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis
by: Timmy Strauss, et al.
Published: (2023-09-01)

Melanoma differentiation-associated gene 5 amyopathic dermatomyositis following an acute Mycoplasma pneumoniae infection: a case report
by: Jessica Hoey, et al.
Published: (2022-11-01)

Juvenile dermatomyositis: Controversies and recent developments in management
by: Himanshi Chaudhary, et al.
Published: (2020-01-01)

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited setting [version 1; peer review: 2 approved, 1 approved with reservations]
by: Dharmagat Bhattarai, et al.
Published: (2023-01-01)

Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
by: Yulu Qiu, et al.
Published: (2024-01-01)

Clinical features and prognostic factors of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
by: Li Lian, et al.
Published: (2023-06-01)